A pharmaceutical composition and the application thereof in the preparation of medicine for the treatment of cerebrovascular diseases

Details for Australian Patent Application No. 2009221546 (hide)

Owner Jiangsu Simcere Pharmaceutical R & D Co., Ltd

Inventors Huang, Xin; He, Jian; Yang, Shibao; Zhang, Anyuan; Jiang, Zheng; Yin, Xiaojin; Li, Xiaoqiang

Agent Davies Collison Cave

Pub. Number AU-B-2009221546

PCT Pub. Number WO2009/109132

Priority 200810020387.1 04.03.08 CN

Filing date 3 March 2009

Wipo publication date 11 September 2009

Acceptance publication date 5 July 2012

International Classifications

A61K 31/4152 - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/045 - Hydroxy compounds, e.g. alcohols

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 9/10 Drugs for disorders of the cardiovascular system

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/109132 Priority application(s): WO2009/109132

5 July 2012 Application Accepted

  Published as AU-B-2009221546

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221571-Manufacture of pipes

2009221478-Use of alternan as texturizing agent in foodstuffs and cosmetics